126 related articles for article (PubMed ID: 33998275)
1. Design, synthesis and cytotoxic evaluation of peptoid analogs of an anticancer active triazolylpeptidyl penicillin.
Martiren NL; Bellizzi Y; Barrionuevo E; Blank VC; Roguin LP; Mata EG; Cornier PG
Future Med Chem; 2021 Jul; 13(13):1127-1139. PubMed ID: 33998275
[No Abstract] [Full Text] [Related]
2. A novel penicillin derivative induces antitumor effect in melanoma cells.
Blank V; Bellizzi Y; Zotta E; Cornier PG; Delpiccolo CML; Boggián DB; Mata EG; Roguin LP
Anticancer Drugs; 2018 Jun; 29(5):416-428. PubMed ID: 29494356
[TBL] [Abstract][Full Text] [Related]
3. Smallest peptoids with antiproliferative activity on human neoplastic cells.
Mas-Moruno C; Cruz LJ; Mora P; Francesch A; Messeguer A; Pérez-Paya E; Albericio F
J Med Chem; 2007 May; 50(10):2443-9. PubMed ID: 17432841
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
7. Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups.
Krieger V; Hamacher A; Gertzen CGW; Senger J; Zwinderman MRH; Marek M; Romier C; Dekker FJ; Kurz T; Jung M; Gohlke H; Kassack MU; Hansen FK
J Med Chem; 2017 Jul; 60(13):5493-5506. PubMed ID: 28574690
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Novel Dehydroepiandrosterone Analogues as Potent Antiproliferative Agents.
Huang X; Shen QK; Zhang HJ; Li JL; Tian YS; Quan ZS
Molecules; 2018 Sep; 23(9):. PubMed ID: 30177642
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes.
Elamari H; Slimi R; Chabot GG; Quentin L; Scherman D; Girard C
Eur J Med Chem; 2013 Feb; 60():360-4. PubMed ID: 23314049
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and molecular docking studies of novel N-benzenesulfonyl-1,2,3,4-tetrahydroisoquinoline-based triazoles with potential anticancer activity.
Pingaew R; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Jun; 81():192-203. PubMed ID: 24836071
[TBL] [Abstract][Full Text] [Related]
13. Bis-triazole-containing Compounds with Anticancer Potential: A Short Review.
Gao M; Diao Q; Gao F; Sun X; Xiao J
Curr Top Med Chem; 2021; 21(18):1674-1691. PubMed ID: 34323190
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Hashemi SM; Mirzaei H; Fallah M; Emami S
Bioorg Chem; 2019 Dec; 93():103300. PubMed ID: 31586708
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, structural characterization and in vitro evaluation of new 1,4-disubstituted-1,2,3-triazole derivatives against glioblastoma cells.
da Silva VD; de Faria BM; Colombo E; Ascari L; Freitas GPA; Flores LS; Cordeiro Y; Romão L; Buarque CD
Bioorg Chem; 2019 Mar; 83():87-97. PubMed ID: 30343205
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of substituted-phenyl-1,2,4-triazol-3-thione analogues with modified D-glucopyranosyl residues and their antiproliferative activities.
Li Z; Gu Z; Yin K; Zhang R; Deng Q; Xiang J
Eur J Med Chem; 2009 Nov; 44(11):4716-20. PubMed ID: 19560842
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3-Triazole-nimesulide hybrid: Their design, synthesis and evaluation as potential anticancer agents.
Mareddy J; Suresh N; Kumar CG; Kapavarapu R; Jayasree A; Pal S
Bioorg Med Chem Lett; 2017 Feb; 27(3):518-523. PubMed ID: 28011214
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors.
Legigan T; Migianu-Griffoni E; Redouane MA; Descamps A; Deschamp J; Gager O; Monteil M; Barbault F; Lecouvey M
Eur J Med Chem; 2021 Mar; 214():113241. PubMed ID: 33571830
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of antiproliferative and antitubulin activities of 5-methyl-4-aryl-3-(4-arylpiperazine-1-carbonyl)-4H-1,2,4-triazoles.
Wang C; Li Y; Liu T; Wang Z; Zhang Y; Bao K; Wu Y; Guan Q; Zuo D; Zhang W
Bioorg Chem; 2020 Nov; 104():103909. PubMed ID: 33142419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
